Table 5.
Control (n = 10) | Type 1 (n = 8) | Type 2 (n = 5) | |
---|---|---|---|
IFN-γ | 317.3 ± 114.59 | 247.3 ± 46.7 | 621.9 ± 542.5 |
p value versus controls | – | 0.460 | 0.129 |
p value versus type 1 | – | – | 0.006 |
MCP-1 | 540.3 ± 261.01 | 1003.5 ± 209.2 | 849.4 ± 317.3 |
p value versus controls | – | 0.001 | 0.040 |
p value versus type 1 | – | – | 0.284 |
MIP-1α | 263.3 ± 226.85 | 842.1 ± 573.8 | 380.4 ± 166.0 |
p value versus controls | – | 0.021 | 0.206 |
p value versus type 1 | – | – | 0.065 |
MIP-1β | 11.4 ± 10.1 | 37.2 ± 29.5 | 26.3 ± 20.1 |
p value versus controls | – | 0.012 | 0.129 |
p value versus type 1 | – | – | 0.724 |
TNFα | 1140.8 ± 377.42 | 836.4 ± 231.6 | 1788.4 ± 1279.4 |
p value versus controls | – | 0.274 | 0.440 |
p value versus type 1 | – | – | 0.019 |
VEGF | 106.3 ± 30.41 | 168.8 ± 60.3 | 350.0 ± 278.4 |
p value versus controls | – | 0.083 | 0.040 |
p value versus type 1 | – | – | 0.354 |
VEGF vascular endothelial growth factor
*Mann-Whitney U test